CareDx, Inc
General ticker "CDNA" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $972.6M (TTM average)
CareDx, Inc follows the US Stock Market performance with the rate: 15.8%.
Estimated limits based on current volatility of 2.3%: low 18.22$, high 19.06$
Factors to consider:
- Total employees count: 650 (+1.1%) as of 2024
- US accounted for 74.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Senior management loss, Labor/talent shortage/retention, Third-party risks, Regulatory and compliance, Economic downturns and volatility
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [13.86$, 25.09$]
- 2026-12-31 to 2027-12-31 estimated range: [13.98$, 25.41$]
Financial Metrics affecting the CDNA estimates:
- Positive: with PPE of 49.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 73.35 > 64.29
- Positive: 0.01 < Operating cash flow per share per price, % of 4.06
- Positive: Investing cash flow per share per price, % of 0.21 > -0.63
- Negative: negative Net income
Short-term CDNA quotes
Long-term CDNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $280.32MM | $333.79MM | $379.81MM |
| Operating Expenses | $483.69MM | $293.02MM | $400.82MM |
| Operating Income | $-203.36MM | $40.77MM | $-21.02MM |
| Non-Operating Income | $13.22MM | $12.09MM | $-0.07MM |
| R&D Expense | $81.87MM | $72.41MM | $71.43MM |
| Income(Loss) | $-190.14MM | $52.86MM | $-21.08MM |
| Taxes | $0.14MM | $0.31MM | $0.27MM |
| Profit(Loss)* | $-190.28MM | $52.55MM | $-21.35MM |
| Stockholders Equity | $261.33MM | $378.43MM | $303.10MM |
| Inventory | $19.47MM | $19.50MM | $26.70MM |
| Assets | $466.83MM | $491.05MM | $413.23MM |
| Operating Cash Flow | $-18.39MM | $38.05MM | $42.03MM |
| Capital expenditure | $9.24MM | $6.48MM | $0.00MM |
| Investing Cash Flow | $40.45MM | $-0.48MM | $2.16MM |
| Financing Cash Flow | $-29.61MM | $-5.61MM | $-93.39MM |
| Earnings Per Share** | $-3.54 | $1.00 | $-0.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.